Market Research Logo

Circulating Tumor Cells - Global Market Outlook (2015-2022)

Circulating Tumor Cells - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Global Circulating Tumor Cells Market is accounted for $4.41 billion in 2015 and is expected to reach $17.96 billion by 2022 growing at a CAGR of 19.2 % from 2015 to 2022. The rising demand for high Benefit-Cost Ratio (BCR) associated with CTCs prognostic technology is the major factor boosting the market growth. Furthermore, advancements in biomedical imaging and bioengineering technology are some of the key factors driving the market. However, high cost associated with the diagnosing and reluctance among people towards adopting highly developed prognostic technologies inhibit the market growth. The recent trends in global Circulating Tumor Cells are strengthening distribution network of CTCs prognostic technologies in emerging economies and the technical advancement of CTCs-based customized medicines.

Tumor cell detection is the foremost product segment primarily due to the advantages related with therapeutic monitoring and high procedure prices. North America region is expected to witness highest growth rate during the forecast period due to increasing demand in number of research projects. In addition, the U.S. Government also supports research by funding various institutes, which grant research funds.

Some of the key players in the market include Adnagen AG, Advanced Cell Diagnostics, Apocell, Aviva Biosciences, Biocep Ltd., Biocept Inc., Biofluidica, Canopus Biosciences, CellTraffix Inc., Clearbridge BioMedics, Creatv Microtech Inc., Cynvenio Biosystems Inc. , Epic Biosciences, Fluxion Biosciences., Greiner Bio-One GmbH, Ikonisys Inc., IV Diagnostics Inc., Janssen Diagnostics, Miltenyi Biotech and Nanostring Technologies Inc.

Technologies Covered:
Tumor Cell Enrichment
Filtration
Centrifugation
Immunological and Immunomagnetic
Tumor Cell Detection
Molecular
Optical

Applications Covered:
Breast Cancer
Colorectal Cancer
Prostate Cancer
Other Applications

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Circulating Tumor Cells Market, By Technology
5.1 Introduction
5.2 Tumor Cell Enrichment
5.2.1 Filtration
5.2.2 Centrifugation
5.2.3 Immunological and Immunomagnetic
5.3 Tumor Cell Detection
5.3.1 Molecular
5.3.2 Optical
6 Global Circulating Tumor Cells Market, By Applications
6.1 Introduction
6.2 Breast Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Other Applications
7 Global Circulating Tumor Cells Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Adnagen AG
9.2 Advanced Cell Diagnostics
9.3 Apocell
9.4 Aviva Biosciences
9.5 Biocep Ltd.
9.6 Biocept Inc.
9.7 Biofluidica
9.8 Canopus Biosciences
9.9 CellTraffix Inc.
9.10 Clearbridge BioMedics
9.11 Creatv Microtech Inc.
9.12 Cynvenio Biosystems Inc.
9.13 Epic Biosciences
9.14 Fluxion Biosciences.
9.15 Greiner Bio-One GmbH
9.16 Ikonisys Inc.
9.17 IV Diagnostics Inc.
9.18 Janssen Diagnostics
9.19 Miltenyi Biotech
9.20 Nanostring Technologies Inc.
List of Tables
Table 1 Global Circulating Tumor Cells Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 3 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 4 Global Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 6 Global Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 7 Global Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 8 Global Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 9 Global Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 10 Global Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 11 North America Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 12 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 13 North America Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 14 North America Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 15 North America Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 16 North America Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 18 North America Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 19 North America Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 20 Europe Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 21 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 22 Europe Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 23 Europe Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 24 Europe Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 25 Europe Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 26 Europe Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 27 Europe Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 28 Aisa Pacific Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 29 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 30 Aisa Pacific Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 31 Aisa Pacific Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 32 Aisa Pacific Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 34 Aisa Pacific Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 35 Aisa Pacific Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 36 Aisa Pacific Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)
Table 37 Rest of the World Circulating Tumor Cells Market Outlook, By Technology (2015-2022) ($MN)
Table 38 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Enrichment (2015-2022) ($MN)
Table 39 Rest of the World Circulating Tumor Cells Market Outlook, By Tumor Cell Detection (2015-2022) ($MN)
Table 40 Rest of the World Circulating Tumor Cells Market Outlook, By Applications (2015-2022) ($MN)
Table 41 Rest of the World Circulating Tumor Cells Market Outlook, By Prostate Cancer (2015-2022) ($MN)
Table 42 Rest of the World Circulating Tumor Cells Market Outlook, By Breast Cancer (2015-2022) ($MN)
Table 43 Rest of the World Circulating Tumor Cells Market Outlook, By Colorectal Cancer (CNS) (2015-2022) ($MN)
Table 44 Rest of the World Circulating Tumor Cells Market Outlook, By Other Applications (2015-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report